Mild, Moderate, or Severe Alzheimer's Disease

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Mild, Moderate, or Severe Alzheimer's Disease trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT06745583

A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease P…

An open-label, exploratory, phase II, proof-of concept, clinical study to assess the safety and tolerability of EI-1071 and the effects of EI-1071 on neuroinfla…

Taiwan15 participantsStarted 2024-12-16

Treatment: EI-1071 tablet, oral

All recent trials (2 shown)

CompletedNot Applicable

NCT01081743

Effectiveness of Care Management in Alzheimer Patients

Context: The French Alzheimer plan 2008-2012 includes the implementation of "disease managers" or social workers, from the onset of the disease, for every patie…

France270 participantsStarted 2009-11-24

Treatment: Intervention of the social worker